Arcutis Biotherapeutics (ARQT) had the lowest return in 2023 by a mid-cap US stock, returning -78.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Arcutis Biotherapeutics (ARQT) | 2023 | -78.61% |
WM Technology (MAPSW) | 2023 | -72.73% |
Uniqure (QURE) | 2023 | -70.38% |
GeneDx (WGS) | 2023 | -69.14% |
SolarEdge Technologies (SEDG) | 2023 | -68.18% |
Nuscale Power (SMR) | 2023 | -67.93% |
Lumen Technologies (LUMN) | 2023 | -65.47% |
Plug Power (PLUG) | 2023 | -64.59% |
Mesoblast (MESO) | 2023 | -62.59% |
Regencell Bioscience (RGC) | 2023 | -62.5% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 2023 | -62.48% |
CommScope (COMM) | 2023 | -62.15% |
Lufax (LU) | 2023 | -59.89% |
Avidity Biosciences (RNA) | 2023 | -59.81% |
Icahn Enterprises (IEP) | 2023 | -59.06% |
PureCycle Technologies (PCTTW) | 2023 | -58.99% |
United Natural Foods (UNFI) | 2023 | -58.42% |
GDS (GDS) | 2023 | -57.99% |
Travere Therapeutics (TVTX) | 2023 | -57.75% |
Akero Therapeutics (AKRO) | 2023 | -57.39% |
Advance Auto Parts (AAP) | 2023 | -57.36% |
Enphase Energy (ENPH) | 2023 | -50.91% |
Perimeter Solutions (PRM) | 2023 | -50.32% |
Sharplink Gaming (SBET) | 2023 | -50% |
VNET Group Inc DRC (VNET) | 2023 | -49.65% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
